HIV pre-exposure prophylaxis and opportunities for vaccination against hepatitis A virus, hepatitis B virus and human papillomavirus: an analysis of the Ontario PrEP cohort study.
Matthew W McGarrityRyan LiskPaul MacPhersonDavid KnoxKevin S WoodwardJeffrey ReinhartJohn MacLeodIsaac I BogochDeanna ClatworthyMia J BiondiSean T SullivanAlan T W LiGarfield DurrantAndrew SchonbeFanta OngoibaJanet RaboudAnn N BurchellDarrell H S TanPublished in: Sexually transmitted infections (2024)
Baseline immunity to HAV/HBV was common, and a sizeable proportion of non-immune participants were vaccinated during follow-up. However, HPV vaccination was uncommon. Continued efforts should be made to remove barriers to HPV vaccination such as cost, inclusion in clinical guidelines and provider recommendation.